FOXO TECHNOLOGIES INC. Sale of Stock, Consideration Received on Transaction
FOXO TECHNOLOGIES INC. (FOXO) reported Sale of Stock, Consideration Received on Transaction of $300.00 thousand for the 1-month period ending 2020-05-29, per its 10-Q filed 2022-08-12.
Discontinued › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2022-08-12
- 2020-05-29: Sale of Stock, Consideration Received on Transaction 1 month $300.00K.
| Period end | Sale of Stock, Consideration Received on Transaction 1 month |
|---|---|
| 2020-05-29 | $300.00K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |